Skip to content

Mitoguazone

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Also known as: Methylglyoxal bis(amidinohydrazone), Methylglyoxal bis(guanylhydrazone)

ATC L01XX16

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Mitoguazone is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including Amd1 and Aoc1.

  • Molecular targets: Amd1 and Aoc1 (2 listed in DrugCentral).
  • ATC code: L01XX16 (Other antineoplastic agents).
  • Molecular formula: C5H12N8; molecular weight 184.21 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
S-adenosylmethionine decarboxylase proenzymeAmd1unknownIC50 6.00
Amiloride-sensitive amine oxidase [copper-containing]Aoc1unknownIC50 5.82

ATC classification

ATC codeTherapeutic hierarchy
L01XX16ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › OTHER ANTINEOPLASTIC AGENTS › Other antineoplastic agents

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Mitoguazone is on its molecule page.

Molecular formulaC5H12N8
Molecular weight184.21 g/mol
CAS number459-86-9
InChIKeyMXWHMTNPTTVWDM-NXOFHUPFSA-N
PubChem CID5351154
C\C(\C=N\NC(N)=N)=N/NC(N)=N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Mitoguazone work?

Its molecular targets in DrugCentral include Amd1 and Aoc1.

What is the chemical formula of Mitoguazone?

Mitoguazone has the molecular formula C5H12N8 and a molecular weight of 184.21 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications0
FormulaC5H12N8
DrugCentral ID3362
Interactive profile